ESOPAug 12, 2026, 05:19 PM
Ascendis Pharma Grants 15,060 Employee Warrants at $254.57 Exercise Price
AI Summary
Ascendis Pharma A/S's board of directors granted an aggregate of 15,060 warrants to certain employees on August 11, 2026. Each warrant confers the right to subscribe for one ordinary share at an exercise price of $254.57. The warrants will vest over time, with 25% vesting after one year and the remainder monthly thereafter, subject to continued service. The company also amended its Articles of Association in connection with this grant.
Key Highlights
- Ascendis Pharma granted 15,060 warrants to employees on August 11, 2026.
- Each warrant has an exercise price of $254.57 per share.
- 25% of the warrants will vest on the one-year anniversary of the grant date.
- The remaining 75% will vest at a rate of 1/36th per month thereafter.
- 1,524,443 shares remain available for future warrant grants.
- The company amended its Articles of Association for this grant.
Price Impact
More from ASND